Omnicare Drugs India

Omnicare Drugs India Private Limited is a pharmaceutical manufacturing company based in Hyderabad, India, and a wholly-owned subsidiary of the UAE-based Neopharma. Established in 2017, the company focuses on the formulation and development of oral solid dosages, liquids, and topical preparations. It operates through strategic partnerships, including a joint venture with Japan's ASKA Pharmaceuticals (NeoAska Pharma) and a stake in Therapiva Private Ltd, which produces active pharmaceutical ingredients (APIs). The company targets key therapeutic areas such as cardiovascular diseases, central nervous system disorders, and diabetes, aiming to supply both domestic and international markets.